Aktham Aburub
Vice President at Eli Lilly and Company
- Role
- Vice President, Research, Synthetic Molecule Design and Development at Eli Lilly and Company
- Location
- Indianapolis, IN, US
- LinkedIn followers
- 500 followers
About Aktham Aburub
Product development leader with extensive experience in the pharmaceutical industry spanning interface with discovery through late stage commercial development and launch. Currently leading product design overseeing novel formulation and drug delivery of synthetic molecules and CMC leader of the oral peptide delivery program at Lilly. Experienced in regulatory submissions utilizing Quality by Design (QbD) with numerous successful interactions with FDA, EMA and PMDA. Awarded the Lilly Progress through Research award (top <0.1% company-wide) for leadership in the development and subsequent approval & launch of Verzenio®. Has been invited to provide training to regulatory agency reviewers on various aspects of product development including novel drug delivery, QbD, Clinically Relevant Specifications and In Vivo Bridging. Adjunct professor at the University of Minnesota, School of Pharmacy and lecturer at the University of Maryland, School of Pharmacy.
Experience
Vice President, Research, Synthetic Molecule Design and Development
Oct 2022 — Present
Education
Jami'at Al-Ulum wa Al-Tiknolojia Al-Urdunia
BSc, Pharmacy
1993 — 1998
University of Iowa
PhD, Pharmaceutics
2000 — 2004
Skills
- Clinical Trials
- Pharmacokinetics
- Quality by Design
- Drug Development
- Pharmaceutical Research
- Formulation
- Drug Delivery
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.